BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6891420)

  • 1. [The metabolic clearance of prostaglandin E1 during cardiopulmonary bypass].
    Kumon K; Tanaka K; Hayashi K; Kishimoto Y; Kosakai Y; Kito Y; Fujita T
    Kyobu Geka; 1982 Nov; 35(11):849-53. PubMed ID: 6891420
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects on hemodynamics during cardiopulmonary bypass at administration of prostaglandin E1 (author's transl)].
    Mizukawa Y
    Nihon Kyobu Geka Gakkai Zasshi; 1981 Sep; 29(9):1417-27. PubMed ID: 7199068
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of prostaglandins A1 and E1 in man.
    Golub M; Zia P; Matsuno M; Horton R
    J Clin Invest; 1975 Dec; 56(6):1404-10. PubMed ID: 1202078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostaglandins E1 and F2 alpha in patients with pulmonary tuberculosis during chemotherapy].
    Sokol TV
    Vrach Delo; 1984 Jun; (6):66-9. PubMed ID: 6591627
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some problems of prostaglandin E1 administration during cardiopulmonary bypass (author's transl)].
    Anzai T; Sakurai T; Iesato H; Sakauchi G
    Kyobu Geka; 1980; 33(9):672-5. PubMed ID: 7420790
    [No Abstract]   [Full Text] [Related]  

  • 6. [A study of erythrocyte deformability and its prevention during cardiopulmonary bypass].
    Akemoto K; Ueyama T; Koto K
    Nihon Kyobu Geka Gakkai Zasshi; 1988 Nov; 36(11):2353-62. PubMed ID: 3062107
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute effect of prostaglandin E1 in severe heart failure--effects on hemodynamics, blood gases and metabolic responses].
    Okano H; Ichikawa T; Nishikawa H; Nakano T; Takezawa H; Morimoto Y; Kodera T; Kanamaru M
    Kokyu To Junkan; 1984 Jul; 32(7):733-40. PubMed ID: 6541803
    [No Abstract]   [Full Text] [Related]  

  • 8. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of cardiopulmonary bypass on the renal tubular cell--the importance of the changes in the ratio of creatinine to blood urea nitrogen].
    Tomiyama Y; Hirano T; Kohyama A; Saito T
    Masui; 1993 Nov; 42(11):1603-10. PubMed ID: 8254868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of prostaglandin E1 on systemic and cerebral oxygenation before and during cardiopulmonary bypass].
    Kawahara F; Kadoi Y
    Masui; 2002 Feb; 51(2):128-33. PubMed ID: 11889777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative evaluation of metabolism in pulsatile and non-pulsatile artificial circulation].
    Dementseva II; Osipov VP; Khodas MIa; Kukaeva EA; Romanov VA
    Anesteziol Reanimatol; 1987; (6):21-4. PubMed ID: 3445947
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical outcome after cardiac operations in patients with cirrhosis.
    Hayashida N; Shoujima T; Teshima H; Yokokura Y; Takagi K; Tomoeda H; Aoyagi S
    Ann Thorac Surg; 2004 Feb; 77(2):500-5. PubMed ID: 14759426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fate of prostaglandins E(1) and A(1) in the human pulmonary circulation.
    Hammond GL; Cronau LH; Whittaker D; Gillis CN
    Surgery; 1977 Jun; 81(6):716-22. PubMed ID: 871015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thyroid-pituitary response to cardiopulmonary bypass].
    Aoyagi S; Shimada S; Kosuga K; Ohishi K
    Rinsho Kyobu Geka; 1988 Oct; 8(5):475-9. PubMed ID: 9301872
    [No Abstract]   [Full Text] [Related]  

  • 15. [Judgment of myocardial protection by the lactate analyzer during the cardiopulmonary bypass].
    Moriya H; Okamoto H; Yasuura K; Takeuchi E; Tanaka M; Murase M; Abe T; Ogawa Y; Seki A
    Rinsho Kyobu Geka; 1987; 7(1):50-4. PubMed ID: 9301757
    [No Abstract]   [Full Text] [Related]  

  • 16. [The study of red cell deformability during cardiopulmonary bypass and the effect of prostaglandin E1].
    Yamaguchi H; Shimizu T; Osada T; Tsuchida H; Motoyasu S; Nagae T; Hirayama T; Kitamura M; Ishimaru S; Furukawa K
    Nihon Kyobu Geka Gakkai Zasshi; 1988 Oct; 36(10):2233-7. PubMed ID: 3209878
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical application of prostaglandin E1 for hypotensive anesthesia (author's transl)].
    Yoshimine K; Oda T; Yoshimura N
    Masui; 1981 Jul; 30(7):664-71. PubMed ID: 7198698
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma catecholamine responses to cardiopulmonary bypass].
    Konno S; Maemura T; Goto K; Maruyama T; Yagi Y; Sasaguri S; Nagase Y; Tanaka H
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Dec; 34(12):2093-9. PubMed ID: 3559309
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of pump flow rate during cardiopulmonary bypass in obese patients avoiding hemodilution.
    Santambrogio L; Leva C; Musazzi G; Bruno P; Vailati A; Zecchillo F; Di Credico G
    J Card Surg; 2009; 24(3):245-9. PubMed ID: 19438775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.